1. Home
  2. MVST vs XBIT Comparison

MVST vs XBIT Comparison

Compare MVST & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microvast Holdings Inc.

MVST

Microvast Holdings Inc.

HOLD

Current Price

$0.65

Market Cap

245.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.18

Market Cap

66.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVST
XBIT
Founded
2006
2005
Country
United States
United States
Employees
1908
87
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.1M
66.8M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
MVST
XBIT
Price
$0.65
$2.18
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
6.9M
45.9K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
85.25
N/A
EPS
N/A
N/A
Revenue
$427,516,000.00
N/A
Revenue This Year
$24.55
N/A
Revenue Next Year
$17.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.56
N/A
52 Week Low
$0.56
$2.09
52 Week High
$7.12
$3.44

Technical Indicators

Market Signals
Indicator
MVST
XBIT
Relative Strength Index (RSI) 40.23 44.72
Support Level N/A $2.19
Resistance Level $1.02 $2.46
Average True Range (ATR) 0.04 0.05
MACD 0.01 -0.00
Stochastic Oscillator 51.99 29.53

Price Performance

Historical Comparison
MVST
XBIT

About MVST Microvast Holdings Inc.

Microvast Holdings Inc develops lithium-ion battery technologies focused on high-performance solutions for commercial and industrial electrification. The Company designs, develops, and manufactures battery components and systems for electric commercial vehicles and energy storage systems (ESS), with applications across buses, trucks, port equipment, and mining machinery. It emphasizes innovation in battery design without relying on legacy technologies and supports platforms such as the IVECO eDaily and various bus models. The Company also provides services, repairs, and warranty and extended warranty support. It operates as a single reportable segment, covering design, development, manufacturing, sales, and leasing of battery systems, and generates the majority of its revenue from Europe.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: